Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 575 of 672 entries
View as:

Study to Evaluate the Safety and Antiviral Activity of Inarigivir Soproxil (Formerly: GS-9992) Plus Tenofovir Alafenamide (TAF) for 12 Weeks in Adults With Chronic Hepatitis B (CHB)

Phase: N/A Priority: Normal
NCT ID: NCT03434353 Org: User:
Start: 02/28/18 End: 01/26/21 Due: 01/26/22

Safety Profile of Idelalisib in Patients With Refractory Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03568929 Org: User:
Start: 05/25/18 End: 10/29/21 Due: 10/29/22

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 12 Weeks in Adults With Chronic Genotype 2 HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02220998 Org: User:
Start: 09/30/14 End: 09/30/15 Due: 09/30/16

Combination of Efavirenz and Truvada - COMET Study

Phase: N/A Priority: Normal
NCT ID: NCT00224458 Org: User:
Start: 09/30/04 End: 02/28/06 Due: 02/28/07

A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments

Phase: N/A Priority: Normal
NCT ID: NCT06337032 Org: User:
Start: 08/27/24 End: 03/31/34 Due: 03/31/35

The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002346 Org: User:
Start: - End: - Due: -

Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus (HCV) Infection

Phase: N/A Priority: Normal
NCT ID: NCT03820258 Org: User:
Start: 01/28/19 End: 02/19/20 Due: 02/19/21

Study of Sacituzumab Govitecan Combinations in First-line Treatment of Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT05186974 Org: User:
Start: 05/30/22 End: 02/28/26 Due: 02/28/27

Open-Label Hepatic Impairment Study

Phase: N/A Priority: Normal
NCT ID: NCT01497327 Org: User:
Start: 07/31/11 End: 01/31/12 Due: 01/31/13

Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04115748 Org: User:
Start: 12/03/19 End: 05/11/21 Due: 05/11/22

Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05101096 Org: User:
Start: 10/20/21 End: 05/31/26 Due: 05/31/27

Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00800579 Org: User:
Start: 11/30/08 End: 02/28/09 Due: 02/28/10

Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.

Phase: N/A Priority: Normal
NCT ID: NCT00423748 Org: User:
Start: 12/31/03 End: 02/28/06 Due: 02/28/07

ESSENTIAL-"The Studies of Oral Enoximone Therapy in Advanced Heart Failure"

Phase: N/A Priority: Normal
NCT ID: NCT00051285 Org: User:
Start: 02/28/02 End: 06/30/05 Due: 06/30/06

D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults

Phase: N/A Priority: Normal
NCT ID: NCT01565850 Org: User:
Start: 04/30/12 End: 02/28/14 Due: 02/28/15

The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002326 Org: User:
Start: - End: - Due: -

Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy

Phase: N/A Priority: Normal
NCT ID: NCT04319198 Org: User:
Start: 08/04/20 End: 10/18/24 Due: 10/18/25

Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis

Phase: N/A Priority: Normal
NCT ID: NCT00805025 Org: User:
Start: 12/31/08 End: 10/31/09 Due: 10/31/10

Study to Assess the Effects of GS-3583 in Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04747470 Org: User:
Start: 03/25/21 End: 11/07/22 Due: 11/07/23

Study to Evaluate the Effects of Two Doses of Seladelpar (MBX-8025) in Subjects With Primary Biliary Cirrhosis (PBC)

Phase: N/A Priority: Normal
NCT ID: NCT02609048 Org: User:
Start: 11/04/15 End: 07/01/16 Due: 07/01/17

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01768286 Org: User:
Start: 01/31/13 End: 02/28/14 Due: 02/28/15

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT02487030 Org: User:
Start: 09/07/15 End: 02/04/17 Due: 02/04/18

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02185794 Org: User:
Start: 06/13/14 End: 09/28/15 Due: 09/28/16

Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant Virus

Phase: N/A Priority: Normal
NCT ID: NCT03472326 Org: User:
Start: 04/03/18 End: 12/09/19 Due: 12/09/20

Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06801834 Org: User:
Start: 04/04/25 End: 10/31/29 Due: 10/31/30